The U.S. government should consider creating a stockpile of infant formula to avoid the possibility of future shortages, the head of the U.S. Food and Drug Administration told a Senate committee last week.
FDA
The infant formula shortage began in mid-February after Abbott Laboratories issued a recall and closed its Sturgis, Michigan plant after several infants became sick and at least two died.
White House press secretary Jen Psaki said the administration is working to “cut red tape,” increase imports of formula and broaden what types of formula are available to participants in the Women, Infants and Children nutrition program.
The U.S. Food and Drug Administration has given a green light to Americans who want to receive a booster dose of a COVID-19 vaccine manufactured by a different company than the one that produced the initial shot they received.
States struggling to provide enough COVID-19 vaccines are likely just a few days away from a pivotal development in the vaccination race: the availability of a shot that requires only one dose.